HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
418.19
+28.57 (7.33%)
At close: Jul 28, 2026, 4:00 PM EDT
418.25
+0.06 (0.01%)
After-hours: Jul 28, 2026, 7:57 PM EDT

HCA Healthcare Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
20,23019,10919,51319,16118,60518,32118,28517,48717,49217,33917,30316,21315,86115,59115,49714,97114,82014,94515,06415,276
Revenue Growth (YoY)
8.73%4.30%6.72%9.57%6.36%5.66%5.67%7.86%10.28%11.21%11.65%8.30%7.02%4.32%2.87%-2.00%2.67%6.93%5.39%14.76%
Cost of Revenue
11,17611,13611,33711,14610,98210,76110,71010,51810,31910,37810,1549,9739,7559,5079,4849,2199,0939,2609,4139,557
Gross Profit
9,0547,9738,1768,0157,6237,5607,5756,9697,1736,9617,1496,2406,1066,0846,0135,7525,7275,6855,6515,719
Depreciation & Amortization Expenses
944930911889863860856842819795789769763756750749738732728716
Other Operating Expenses
5,0434,1804,0874,1613,7933,8453,8733,7173,6233,6063,5593,3793,0432,8942,8502,8602,6932,7522,5372,530
Total Operating Expenses
5,9875,1104,9985,0504,6564,7054,7294,5594,4424,4014,3484,1483,8063,6503,6003,6093,4313,4843,2653,246
Operating Income
3,0672,8633,1782,9652,9672,8552,8462,4102,7312,5602,8012,0922,3002,4342,4132,1432,2962,2012,3862,473
Interest Income
169251619181015--22819-7-1816108113535
Interest Expense
-599-584-572-561-568-547-528-515-506-512-491-483-485-479-453-446-434-408-398-398
Other Non-Operating Income (Expense)
10-141-2-31-195-412201721-151,326-3-110105631,047
Total Non-Operating Income (Expense)
-573-576-506-547-552-528-713-504-494-313-456-462-491-512889-439-536-387200684
Pretax Income
2,4942,2872,6722,4182,4152,3272,1331,9062,2372,2472,3451,6301,8091,9223,3021,7041,7601,8142,5863,157
Provision for Income Taxes
564430509515524502447424550445484355397379656360381349581685
Net Income
1,9301,8572,1631,9031,8911,8251,6861,4821,6871,8021,8611,2751,4121,5432,6462,6881,3791,4652,0052,472
Minority Interest in Earnings
231237285260238215248212226211254196219180565210224192191203
Net Income to Common
1,6991,6201,8781,6431,6531,6101,4381,2701,4611,5911,6071,0791,1931,3632,0811,1341,1551,2731,8142,269
Net Income Growth (YoY)
2.78%0.62%30.60%29.37%13.14%1.19%-10.52%17.70%22.46%16.73%-22.78%-4.85%3.29%7.07%14.72%-50.02%-20.34%-10.54%27.21%239.67%
Shares Outstanding (Basic)
221224231233239247255257261264271271274277286286293302315318
Shares Outstanding (Diluted)
223227231236242249255260264268271275278281286290296307315324
Shares Change (YoY)
-7.89%-9.14%-9.63%-9.13%-8.39%-6.93%-5.85%-5.63%-5.08%-4.61%-5.07%-4.98%-6.03%-8.59%-9.43%-10.55%-10.99%-10.47%-8.67%-5.63%
EPS (Basic)
7.707.258.147.056.916.525.634.945.606.015.933.984.354.927.283.973.954.215.757.13
EPS (Diluted)
7.627.158.146.966.836.455.634.885.535.935.933.914.294.857.283.913.904.145.757.00
EPS Growth (YoY)
11.57%10.85%44.58%42.62%23.51%8.77%-5.06%24.81%28.90%22.27%-18.54%0%10.00%17.15%26.61%-44.14%-10.55%0%39.23%258.97%

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
1,1048958703,1283,0346601,2742,3246901,3511,5151,3321,2346061,2041,8895504841,2511,388
Free Cash Flow Growth (YoY)
-63.61%35.61%-31.71%34.60%339.71%-51.15%-15.91%74.47%-44.08%122.94%25.83%-29.49%124.36%25.21%-3.76%36.09%-60.97%-63.72%--37.70%
Free Cash Flow Per Share
4.953.953.7713.2412.542.654.998.942.615.045.594.844.442.164.216.521.861.573.974.28
Dividends Per Share
0.7800.7800.7200.7200.7200.7200.6600.6600.6600.6600.6000.6000.6000.6000.5600.5600.5600.5600.4800.480
Dividend Growth (YoY)
8.33%8.33%9.09%9.09%9.09%9.09%10.00%10.00%10.00%10.00%7.14%7.14%7.14%7.14%16.67%16.67%16.67%16.67%--
Gross Margin
44.76%41.72%41.90%41.83%40.97%41.26%41.43%39.85%41.01%40.15%41.32%38.49%38.50%39.02%38.80%38.42%38.64%38.04%37.51%37.44%
Operating Margin
15.16%14.98%16.29%15.47%15.95%15.58%15.56%13.78%15.61%14.76%16.19%12.90%14.50%15.61%15.57%14.31%15.49%14.73%15.84%16.19%
Profit Margin
9.54%9.72%11.08%9.93%10.16%9.96%9.22%8.47%9.64%10.39%10.76%7.86%8.90%9.90%17.07%17.95%9.30%9.80%13.31%16.18%
FCF Margin
5.46%4.68%4.46%16.32%16.31%3.60%6.97%13.29%3.94%7.79%8.76%8.22%7.78%3.89%7.77%12.62%3.71%3.24%8.30%9.09%
EBITDA
4,0113,7934,0893,8543,8303,7153,7023,2523,5503,3553,5902,8613,0633,1903,1632,8923,0342,9333,1143,189
EBITDA Margin
19.83%19.85%20.96%20.11%20.59%20.28%20.25%18.60%20.29%19.35%20.75%17.65%19.31%20.46%20.41%19.32%20.47%19.63%20.67%20.88%
EBIT
3,0672,8633,1782,9652,9672,8552,8462,4102,7312,5602,8012,0922,3002,4342,4132,1432,2962,2012,3862,473
EBIT Margin
15.16%14.98%16.29%15.47%15.95%15.58%15.56%13.78%15.61%14.76%16.19%12.90%14.50%15.61%15.57%14.31%15.49%14.73%15.84%16.19%
Effective Tax Rate
22.61%18.80%19.05%21.30%21.70%21.57%20.96%22.25%24.59%19.80%20.64%21.78%21.95%19.72%19.87%21.13%21.65%19.24%22.47%21.70%
SEC Filings: 10-K · 10-Q